Fotemustine, etoposide, citosina-arabinoside e melphalan (FEAM), un nuovo regime di condizionamento per autotrapianto di cellule staminali in pazienti affetti da linfoma

Translated title of the contribution: Fotemustine, etoposide, cytosine arabinoside and melphalan (FEAM): A new conditioning regimen for the hematopoietic stem cell autotransplant in patients with lymphoma

M. Musso, R. Scalone, A. Crescimanno, A. Pinto, G. Marcacci, N. Cascavilla, P. R. Scalzulli, N. Di Renzo, R. Matera, A. D'Arco, F. Lanza, P. Di Bartolomeo, P. Di Carlo, T. Perrone, C. Bianchini

Research output: Contribution to journalArticlepeer-review

Translated title of the contributionFotemustine, etoposide, cytosine arabinoside and melphalan (FEAM): A new conditioning regimen for the hematopoietic stem cell autotransplant in patients with lymphoma
Original languageItalian
Pages (from-to)133-134
Number of pages2
JournalHaematologica Meeting Reports
Volume2
Issue number6
Publication statusPublished - 2008

ASJC Scopus subject areas

  • Hematology

Cite this